EW Related Earnings News
-
Edwards Lifesciences (EW) Likely to Win German Injunction in Dispute W/ Medtronic (MDT)
-
UBS See More Downside in Edwards Lifesciences (EW), PT Lowered to $64
-
Edwards Lifesciences Corp. (EW) Misses Q1 EPS by 4c, Lowers Guidance
-
Edwards Lifesciences (EW) Experiences Rubust Heart Valve Sales, Analyst Sees Upside
-
Edwards Lifesciences Corp. (EW) Tops Q4 EPS by 13c; Guides Q1, FY13
-
Edwards Lifesciences (EW) Predicts Growth in 2013
-
UPDATE: Edwards Lifesciences (EW) Posts Q3 EPS of 58c; Sees FY12 Revs at Low-End of Range, Guides 4
-
Canaccord Genuity Defends Edwards Lifesciences (EW)
-
Goldman Sachs Slashes PT on Edwards Lifesciences (EW), Maintains Buy
-
Edwards Lifesciences (EW) Pre-announces Disappointing Revenue
-
Jefferies Reiterated Buy on Edwards Lifesciences (EW) after Surveys Show Favorable Results
-
Goldman Reiterates Buy on Edwards Lifesciences (EW)
-
Canaccord Genuity Reiterates a 'Buy' on Edwards Lifesciences (EW); TAVI Crushes It
-
Edwards Lifesciences Corp. (EW) Tops Q2 EPS by 2c; Guides Q3 Below the Street
-
UPDATE: UBS Downgrades Edwards Lifesciences (EW) to Neutral; TAVI Outlook Strong, But Already Priced In
-
Canaccord Genuity Raises PT and Estimates on Edwards Lifesciences (EW); Preview of Cohort A Panel
-
GARP Research Maintains a 'Buy' on Edwards Lifesciences (EW); Hospiteal Interest in TAVI Remains High
-
Canaccord Genuity Suggests Adding To Positions in Edwards Lifesciences (EW); Buy Ahead of Catalysts
-
Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 5c; Trims FY12 EPS Range
-
Goldman Sachs Maintains Top Rating on Edwards Lifesciences (EW), But Trims Numbers
-
Canaccord Genuity Maintains a 'Buy' on Edwards Lifesciences (EW); Adjusting Estimates
-
Edwards Lifesciences (EW) to Restate Financial Statements for First Three Quarters of 2011
-
Edwards Lifesciences Corp. (EW) Posts Mixed Q4 Results
-
Edwards Lifesciences (EW) to Outline FY12 Outlook; Guides EPS, Revs In-Line
-
Edwards (EW) Accepts Coverage Curbs on Heart Valves; Bloomberg Says Rules Could Cut US Sales by $100M
-
Edwards Lifesciences Corp. (EW) Misses Q3 EPS by 1c
-
Edwards Lifesciences Corp. (EW) Misses Q2 EPS by 1c, Reaffirms FY11 Guidance
-
Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 9c; Increases FY11 EPS Outlook, Guides Q2
-
Edwards Lifesciences Corp. (EW) Tops Q4 EPS by 2c; Mixed Guidance
-
Edwards Lifesciences (EW) Anounces FY11 Outlook; Other Growth Initiatives
-
Edwards Lifesciences (EW) Reports Mixed Q3 Results; Guides Q4, Revises FY10 Outlook
-
Edwards Lifesciences (EW) Reports Q2 EPS of $0.48, Beats by 4c; Guides Q3, FY10 EPS
-
Edwards Lifesciences (EW) Reports Mixed Q1 Results; Raises Low End of FY10 EPS Guidance
-
Edwards Lifesciences (EW) Misses Q4 EPS by 1c; Guides In-Line
-
Edwards Lifesciences (EW) Guides FY10 Sales Inline
-
Edwards Lifesciences (EW) Tops Q3 Views
-
Edwards Lifesciences (EW) Tops Q2 EPS by 5c; Issues Mixed Guidance
-
Edwards Lifesciences (EW) Tops Q1 Views; Guides Q2, FY09
-
Edwards Lifesciences (EW) Tops Q4 EPS by 2c, Guides In-line for Q1 and FY09
-
Edwards Lifesciences (EW) Issues Mixed Guidance for FY09
-
Edwards Lifesciences (EW) Reports Mixed Q3 Earnings; Guides Q4, Raises FY08 EPS Outlook
-
Edwards Lifesciences (EW) Tops Q2 EPS by 2c, Guides Above for FY08 Revenues
-
Edwards Lifesciences (EW) Beats 7c, Beats Revenue Targes And Guides Higher
-
Edwards Lifesciences (EW) Tops Q4 View; Guides FY08
-
Edwards Lifesciences (EW) Beats Q3 Estimates
-
Edwards Lifesciences (EW) Reports In-Line Q2; Guides Below
-
Edwards Lifesciences (EW) Misses Q1 EPS by 2c; Guides
-
Edwards Lifesciences (EW) Tops Q4 EPS by 2c, Guides In-line for FY07
-
Edwards Lifesciences (EW) Provides Update to 2007 Guidance
-
Edwards Lifesciences (EW) to Discontinue its Optiwave 980 Cardiac Laser Ablation System, Sees $16 Million Charge in Q4
Back to EW Stock Lookup
